ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
DEL PRIS
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership200 shares
Latest Disclosed Value $ 15,788
Group One Trading, L.p. ownership in BSFA / ANI Pharmaceuticals, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 200 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $15,788 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 0 shares of ANI Pharmaceuticals, Inc.. The current value of the position is $10,900 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (BSFA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:BSFA / ANI Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 200 200 16 0.0000
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -1,623 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,623 -149 -8.41 106 -11.02 0.0002
2025-05-14 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,772 1,772 119 0.0003
2025-05-14 2024-12-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 0 -321 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -321 0
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 321 321 19 0.0001
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -3,312 -100.00 0 -100.00
2024-05-10 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 3,312 3,312 229 0.0009
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -481 -100.00 0 -100.00
2023-11-09 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 481 -981 -67.10 28 -65.38 0.0001
2023-08-09 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,462 1,462 79 0.0003
2021-02-10 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -61 -100.00 0 -100.00
2020-11-12 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 61 61 2 0.0000
2020-02-10 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -4,000 -100.00 0 -100.00
2019-11-12 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 4,000 4,000 292 0.0024
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 0 0 0.0000
2016-02-11 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -3,657 -100.00 0 -100.00
2015-11-20 2015-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 3,657 3,301 927.25 144 4,700.00 0.0020
2015-11-06 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 3,657 144
2013-11-15 2013-09-30 13F ANI PHARMACEUTICALS COM 00182C103 356 356 3 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM Call 700 0.00 64 42.22 n/a n/a n/a
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM Call 700 46 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM Call 300 18 n/a n/a n/a
2023-11-09 2023-09-30 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-09 2023-06-30 13F ANI PHARMACEUTICALS COM Call 400 0.00 22 40.00 n/a n/a n/a
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM Call 400 16 n/a n/a n/a
2023-02-09 2022-12-31 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F ANI PHARMACEUTICALS COM Call 100 32 n/a n/a n/a
2022-08-11 2022-06-30 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ANI PHARMACEUTICALS COM Call 400 11 n/a n/a n/a
2020-08-13 2020-06-30 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F ANI PHARMACEUTICALS COM Call 200 0.00 8 -33.33 n/a n/a n/a
2020-02-10 2019-12-31 13F ANI PHARMACEUTICALS COM Call 200 -33.33 12 -45.45 n/a n/a n/a
2019-11-12 2019-09-30 13F ANI PHARMACEUTICALS COM Call 300 -94.34 22 -94.95 n/a n/a n/a
2019-08-09 2019-06-30 13F ANI PHARMACEUTICALS COM Call 5,300 436 n/a n/a n/a
2018-11-08 2018-09-30 13F ANI PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-13 2018-06-30 13F ANI PHARMACEUTICALS COM Call 38,000 -11.63 2,538 1.40 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ANI PHARMACEUTICALS COM Call 43,000 551.52 2,503 488.94 n/a n/a n/a
2018-05-10 2018-03-31 13F ANI PHARMACEUTICALS COM Call 43,000 2,503 n/a n/a n/a
2018-02-09 2017-12-31 13F ANI PHARMACEUTICALS COM Call 6,600 1.54 425 24.63 n/a n/a n/a
2017-11-15 2017-09-30 13F ANI PHARMACEUTICALS COM Call 6,500 550.00 341 625.53 n/a n/a n/a
2017-08-14 2017-06-30 13F ANI PHARMACEUTICALS COM Call 1,000 11.11 47 4.44 n/a n/a n/a
2017-05-10 2017-03-31 13F ANI PHARMACEUTICALS COM Call 900 -86.76 45 -89.08 n/a n/a n/a
2017-02-15 2016-12-31 13F ANI PHARMACEUTICALS COM Call 6,800 -39.82 412 -45.07 n/a n/a n/a
2016-11-14 2016-09-30 13F ANI PHARMACEUTICALS COM Call 11,300 101.79 750 139.62 n/a n/a n/a
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS COM Call 5,600 -53.33 313 -22.52 n/a n/a n/a
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS COM Call 12,000 -75.76 404 -81.92 n/a n/a n/a
2016-02-11 2015-12-31 13F ANI PHARMACEUTICALS COM Call 49,500 105.39 2,234 134.66 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ANI PHARMACEUTICALS COM Call 24,100 16.43 952 -25.86 n/a n/a n/a
2015-11-06 2015-09-30 13F ANI PHARMACEUTICALS COM Call 24,100 952 n/a n/a n/a
2015-08-11 2015-06-30 13F ANI PHARMACEUTICALS COM Call 20,700 158.75 1,284 156.80 n/a n/a n/a
2015-05-14 2015-03-31 13F ANI PHARMACEUTICALS COM Call 8,000 14.29 500 26.58 n/a n/a n/a
2015-02-11 2014-12-31 13F ANI PHARMACEUTICALS COM Call 7,000 -93.93 395 -82.94 n/a n/a n/a
2014-01-31 2013-12-31 13F ANI PHARMACEUTICALS COM Call 115,300 -0.43 2,315 104.69 n/a n/a n/a
2013-11-15 2013-09-30 13F ANI PHARMACEUTICALS COM Call 115,800 1,131 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-14 2024-12-31 13F/A ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM Put 2,000 119 n/a n/a n/a
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ANI PHARMACEUTICALS COM Put 25,000 1,728 n/a n/a n/a
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F ANI PHARMACEUTICALS COM Put 2,000 0.00 116 8.41 n/a n/a n/a
2023-08-09 2023-06-30 13F ANI PHARMACEUTICALS COM Put 2,000 0.00 108 35.44 n/a n/a n/a
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM Put 2,000 79 n/a n/a n/a
2022-11-09 2022-09-30 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-11 2022-06-30 13F ANI PHARMACEUTICALS COM Put 500 150.00 15 150.00 n/a n/a n/a
2022-05-12 2022-03-31 13F ANI PHARMACEUTICALS COM Put 200 0.00 6 -33.33 n/a n/a n/a
2022-02-11 2021-12-31 13F ANI PHARMACEUTICALS COM Put 200 9 n/a n/a n/a
2020-05-12 2020-03-31 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F ANI PHARMACEUTICALS COM Put 100 -98.04 6 -98.39 n/a n/a n/a
2019-11-12 2019-09-30 13F ANI PHARMACEUTICALS COM Put 5,100 2,450.00 372 2,225.00 n/a n/a n/a
2019-08-09 2019-06-30 13F ANI PHARMACEUTICALS COM Put 200 16 n/a n/a n/a
2018-08-13 2018-06-30 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ANI PHARMACEUTICALS COM Put 2,500 -46.81 146 -51.82 n/a n/a n/a
2018-05-10 2018-03-31 13F ANI PHARMACEUTICALS COM Put 2,500 146 n/a n/a n/a
2018-02-09 2017-12-31 13F ANI PHARMACEUTICALS COM Put 4,700 370.00 303 482.69 n/a n/a n/a
2017-11-15 2017-09-30 13F ANI PHARMACEUTICALS COM Put 1,000 66.67 52 85.71 n/a n/a n/a
2017-08-14 2017-06-30 13F ANI PHARMACEUTICALS COM Put 600 -83.33 28 -84.27 n/a n/a n/a
2017-05-10 2017-03-31 13F ANI PHARMACEUTICALS COM Put 3,600 200.00 178 143.84 n/a n/a n/a
2017-02-15 2016-12-31 13F ANI PHARMACEUTICALS COM Put 1,200 -47.83 73 -52.29 n/a n/a n/a
2016-11-14 2016-09-30 13F ANI PHARMACEUTICALS COM Put 2,300 -56.60 153 -48.31 n/a n/a n/a
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS COM Put 5,300 -13.11 296 44.39 n/a n/a n/a
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS COM Put 6,100 510.00 205 355.56 n/a n/a n/a
2016-02-11 2015-12-31 13F ANI PHARMACEUTICALS COM Put 1,000 45 n/a n/a n/a
2015-11-06 2015-09-30 13F ANI PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F ANI PHARMACEUTICALS COM Put 100 0.00 6 500.00 n/a n/a n/a
2013-11-15 2013-09-30 13F ANI PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.